# Flexsteel Industries Inc: financial statements, quarterly

FLXS · Nasdaq · CIK 37472 · [Materials](/sectors/materials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/flxs.md) · [Financials](/companies/flxs/financials.md) · [Filings](/companies/flxs/filings.md) · [Insiders](/companies/flxs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/flxs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [100](/filings/0000950170-25-110965.md) | [107](/filings/0000950170-25-110965.md) | [111](/filings/0000950170-25-110965.md) | [104](/filings/0001193125-25-246951.md) | [108](/filings/0001193125-26-037679.md) | [114](/filings/0001193125-26-170444.md) | [115](/filings/0000950170-25-110965.md) | [110](/filings/0001193125-26-436394.md) | [118](/filings/0001193125-26-037679.md) | [115](/filings/0001193125-26-170444.md) | [115 d](/filings/0001193125-26-357097.md) | [114](/filings/0001193125-26-436394.md) |
| Cost of revenue | $m | [78.2](/filings/0000950170-25-014645.md) | [83.9](/filings/0000950170-25-057522.md) | [87.3 d](/filings/0001193125-26-357097.md) | [81.6](/filings/0001193125-25-246951.md) | [85.7](/filings/0001193125-26-037679.md) | [88.6](/filings/0001193125-26-170444.md) | [87.2 d](/filings/0001193125-26-357097.md) | [84.5](/filings/0001193125-26-436394.md) | [91.4](/filings/0001193125-26-037679.md) | [89.1](/filings/0001193125-26-170444.md) | [80.7 d](/filings/0001193125-26-357097.md) | [88.9](/filings/0001193125-26-436394.md) |
| Gross profit | $m | [22.0](/filings/0000950170-25-110965.md) | [23.3](/filings/0000950170-25-110965.md) | [23.6](/filings/0000950170-25-110965.md) | [22.4](/filings/0001193125-25-246951.md) | [22.8](/filings/0001193125-26-037679.md) | [25.3](/filings/0001193125-26-170444.md) | [27.4](/filings/0000950170-25-110965.md) | [25.9](/filings/0001193125-26-436394.md) | [26.8](/filings/0001193125-26-037679.md) | [26.0](/filings/0001193125-26-170444.md) | [34.6 d](/filings/0001193125-26-357097.md) | [25.1](/filings/0001193125-26-436394.md) |
| Selling, general and administrative | $m | [17.4](/filings/0000950170-25-014645.md) | [17.7](/filings/0000950170-25-057522.md) | [18.9 d](/filings/0001193125-26-357097.md) | [16.3](/filings/0001193125-25-246951.md) | [16.1](/filings/0001193125-26-037679.md) | [17.1](/filings/0001193125-26-170444.md) | [17.2 d](/filings/0001193125-26-357097.md) | [17.0](/filings/0001193125-26-436394.md) | [17.8](/filings/0001193125-26-037679.md) | [17.8](/filings/0001193125-26-170444.md) | [18.3 d](/filings/0001193125-26-357097.md) | [18.2](/filings/0001193125-26-436394.md) |
| Operating income | $m | [4.6](/filings/0000950170-25-110965.md) | [3.0](/filings/0000950170-25-110965.md) | [7.6](/filings/0000950170-25-110965.md) | [6.0](/filings/0001193125-25-246951.md) | [11.7](/filings/0001193125-26-037679.md) | [(5.1)](/filings/0001193125-26-170444.md) | [14.0](/filings/0000950170-25-110965.md) | [9.0](/filings/0001193125-26-436394.md) | [9.0](/filings/0001193125-26-037679.md) | [8.2](/filings/0001193125-26-170444.md) | [16.3 d](/filings/0001193125-26-357097.md) | [6.9](/filings/0001193125-26-436394.md) |
| Interest expense | $m | [0.5](/filings/0000950170-25-014645.md) | [0.3](/filings/0000950170-25-057522.md) | [0.2 d](/filings/0001193125-26-357097.md) | [0.1](/filings/0001193125-25-246951.md) | [(0.0)](/filings/0001193125-26-037679.md) | [0.0](/filings/0000950170-25-057522.md) | [0.0 d](/filings/0001193125-26-357097.md) | [0.0](/filings/0001193125-25-246951.md) | [0.0](/filings/0001193125-26-037679.md) | not reported | not reported | [0.0](/filings/0001193125-26-436394.md) |
| Income tax | $m | [1.0](/filings/0000950170-25-014645.md) | [0.9](/filings/0000950170-25-057522.md) | [2.5 d](/filings/0001193125-26-357097.md) | [1.9](/filings/0001193125-25-246951.md) | [2.6](/filings/0001193125-26-037679.md) | [(1.2)](/filings/0001193125-26-170444.md) | [3.6 d](/filings/0001193125-26-357097.md) | [2.1](/filings/0001193125-26-436394.md) | [2.7](/filings/0001193125-26-037679.md) | [2.1](/filings/0001193125-26-170444.md) | [3.8 d](/filings/0001193125-26-357097.md) | [1.5](/filings/0001193125-26-436394.md) |
| Net income | $m | [3.1](/filings/0000950170-25-110965.md) | [1.8](/filings/0000950170-25-110965.md) | [4.9](/filings/0000950170-25-110965.md) | [4.1](/filings/0001193125-26-170444.md) | [9.1](/filings/0001193125-26-170444.md) | [(3.7)](/filings/0001193125-26-170444.md) | [10.7](/filings/0000950170-25-110965.md) | [7.3](/filings/0001193125-26-436394.md) | [6.6](/filings/0001193125-26-170444.md) | [6.4](/filings/0001193125-26-170444.md) | [12.7 d](/filings/0001193125-26-357097.md) | [5.4](/filings/0001193125-26-436394.md) |
| Diluted EPS | $ per share | [0.57](/filings/0000950170-25-110965.md) | [0.33](/filings/0000950170-25-110965.md) | [0.89](/filings/0000950170-25-110965.md) | [0.74](/filings/0001193125-25-246951.md) | [1.62](/filings/0001193125-26-037679.md) | [(0.71)](/filings/0001193125-26-170444.md) | [1.89](/filings/0000950170-25-110965.md) | [1.31](/filings/0001193125-26-436394.md) | [1.18](/filings/0001193125-26-037679.md) | [1.14](/filings/0001193125-26-170444.md) | not reported | [1.24](/filings/0001193125-26-436394.md) |
| Basic EPS | $ per share | [0.59](/filings/0000950170-25-110965.md) | [0.35](/filings/0000950170-25-110965.md) | [0.95](/filings/0000950170-25-110965.md) | [0.80](/filings/0001193125-25-246951.md) | [1.73](/filings/0001193125-26-037679.md) | [(0.71)](/filings/0001193125-26-170444.md) | [2.03](/filings/0000950170-25-110965.md) | [1.38](/filings/0001193125-26-436394.md) | [1.24](/filings/0001193125-26-037679.md) | [1.20](/filings/0001193125-26-170444.md) | not reported | [1.32](/filings/0001193125-26-436394.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.3](/filings/0000950170-24-012208.md) | [4.6](/filings/0000950170-24-051378.md) | [4.8](/filings/0000950170-25-110965.md) | [5.7](/filings/0000950170-24-116719.md) | [11.8](/filings/0000950170-25-014645.md) | [22.6](/filings/0000950170-25-057522.md) | [40.0](/filings/0001193125-26-357097.md) | [38.6](/filings/0001193125-25-246951.md) | [36.8](/filings/0001193125-26-037679.md) | [57.3](/filings/0001193125-26-170444.md) | [16.7](/filings/0001193125-26-436394.md) | [4.4](/filings/0001193125-26-436394.md) |
| Current assets | $m | [149](/filings/0000950170-24-012208.md) | [150](/filings/0000950170-24-051378.md) | [155](/filings/0000950170-25-110965.md) | [152](/filings/0000950170-24-116719.md) | [149](/filings/0000950170-25-014645.md) | [157](/filings/0000950170-25-057522.md) | [172](/filings/0001193125-26-357097.md) | [175](/filings/0001193125-25-246951.md) | [189](/filings/0001193125-26-037679.md) | [200](/filings/0001193125-26-170444.md) | [158](/filings/0001193125-26-436394.md) | [148](/filings/0001193125-26-436394.md) |
| Total assets | $m | [272](/filings/0000950170-24-012208.md) | [274](/filings/0000950170-24-051378.md) | [274](/filings/0000950170-25-110965.md) | [269](/filings/0000950170-24-116719.md) | [272](/filings/0000950170-25-014645.md) | [266](/filings/0000950170-25-057522.md) | [282](/filings/0001193125-26-357097.md) | [281](/filings/0001193125-25-246951.md) | [290](/filings/0001193125-26-037679.md) | [290](/filings/0001193125-26-170444.md) | [254](/filings/0001193125-26-436394.md) | [243](/filings/0001193125-26-436394.md) |
| Current liabilities | $m | [48.6](/filings/0000950170-24-012208.md) | [53.7](/filings/0000950170-24-051378.md) | [60.4](/filings/0000950170-25-110965.md) | [53.3](/filings/0000950170-24-116719.md) | [50.9](/filings/0000950170-25-014645.md) | [53.5](/filings/0000950170-25-057522.md) | [62.0](/filings/0001193125-26-357097.md) | [58.5](/filings/0001193125-25-246951.md) | [62.6](/filings/0001193125-26-037679.md) | [58.2](/filings/0001193125-26-170444.md) | [75.7](/filings/0001193125-26-436394.md) | [68.0](/filings/0001193125-26-436394.md) |
| Total liabilities | $m | [129](/filings/0000950170-24-012208.md) | [129](/filings/0000950170-24-051378.md) | [124](/filings/0000950170-25-110965.md) | [114](/filings/0000950170-24-116719.md) | [110](/filings/0000950170-25-014645.md) | [108](/filings/0000950170-25-057522.md) | [115](/filings/0001193125-26-357097.md) | [109](/filings/0001193125-25-246951.md) | [111](/filings/0001193125-26-037679.md) | [105](/filings/0001193125-26-170444.md) | [121](/filings/0001193125-26-436394.md) | [110](/filings/0001193125-26-436394.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [144](/filings/0000950170-25-057522.md) | [145](/filings/0000950170-25-057522.md) | [150](/filings/0001193125-26-357097.md) | [155](/filings/0001193125-26-170444.md) | [162](/filings/0001193125-26-170444.md) | [158](/filings/0001193125-26-170444.md) | [168](/filings/0001193125-26-436394.md) | [172](/filings/0001193125-26-436394.md) | [179](/filings/0001193125-26-170444.md) | [185](/filings/0001193125-26-170444.md) | [133](/filings/0001193125-26-436394.md) | [132](/filings/0001193125-26-436394.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.9 d](/filings/0000950170-25-014645.md) | [7.2 d](/filings/0000950170-25-057522.md) | [7.5 d](/filings/0001193125-26-357097.md) | [2.4](/filings/0001193125-25-246951.md) | [6.7 d](/filings/0001193125-26-037679.md) | [12.3 d](/filings/0001193125-26-170444.md) | [15.6 d](/filings/0001193125-26-357097.md) | [4.1](/filings/0001193125-26-436394.md) | [1.0 d](/filings/0001193125-26-037679.md) | [22.1 d](/filings/0001193125-26-170444.md) | [24.3 d](/filings/0001193125-26-357097.md) | [(1.5)](/filings/0001193125-26-436394.md) |
| Capital expenditure | $m | [1.7 d](/filings/0000950170-25-014645.md) | [1.3 d](/filings/0000950170-25-057522.md) | [0.4 d](/filings/0001193125-26-357097.md) | [0.4](/filings/0001193125-25-246951.md) | [0.9 d](/filings/0001193125-26-037679.md) | [1.4 d](/filings/0001193125-26-170444.md) | [0.6 d](/filings/0001193125-26-357097.md) | [1.4](/filings/0001193125-26-436394.md) | [1.7 d](/filings/0001193125-26-037679.md) | [0.4 d](/filings/0001193125-26-170444.md) | [0.4 d](/filings/0001193125-26-357097.md) | [1.0](/filings/0001193125-26-436394.md) |
| Dividends paid | $m | [0.8 d](/filings/0000950170-25-014645.md) | [0.8 d](/filings/0000950170-25-057522.md) | [0.8 d](/filings/0001193125-26-357097.md) | [0.9](/filings/0001193125-25-246951.md) | [0.9 d](/filings/0001193125-26-037679.md) | [0.9 d](/filings/0001193125-26-170444.md) | [0.9 d](/filings/0001193125-26-357097.md) | [1.1](/filings/0001193125-26-436394.md) | [1.1 d](/filings/0001193125-26-037679.md) | [1.1 d](/filings/0001193125-26-170444.md) | [1.1 d](/filings/0001193125-26-357097.md) | [1.1](/filings/0001193125-26-436394.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,339](/filings/0000950170-24-012208.md) | [5,352](/filings/0000950170-24-051378.md) | [5,375](/filings/0000950170-24-116719.md) | [5,324](/filings/0000950170-25-014645.md) | [5,448](/filings/0000950170-25-057522.md) | [5,576](/filings/0001193125-25-246951.md) | [5,582](/filings/0001193125-26-037679.md) | [5,271](/filings/0001193125-26-170444.md) | [5,598](/filings/0001193125-26-436394.md) | [5,633](/filings/0001193125-26-037679.md) | [5,664](/filings/0001193125-26-170444.md) | [4,365](/filings/0001193125-26-436394.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,161,973 at 2026-10-28, from the cover of the [10-Q filed 2026-10-28](/filings/0001193125-26-436394.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 05:20 ET. No prices; not investment advice.